ARCHIVES

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

This article is from The Cancer Letter archive.

Vol. 15 No. 32 | August 11, 1989

Download PDF Visit The Full Archive

Related Articles

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010